Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 41,176 |
| Gross Profit | N/A | N/A | N/A | N/A | 41,176 |
| Operating Expenses | 21,848 | 23,120 | 25,231 | 45,366 | 39,329 |
| Operating Income | -21,848 | -23,120 | -25,231 | -45,366 | 1,847 |
| Other Income | 23,287 | -6,886 | -6,877 | -6,344 | 94 |
| Pre-tax Income | 1,439 | -30,005 | -32,109 | -51,709 | 1,941 |
| Income Tax | N/A | N/A | N/A | -1,803 | N/A |
| Net Income Continuous | 1,439 | -30,005 | -32,109 | -49,906 | 1,941 |
| Net Income | $1,439 | $-30,005 | $-32,109 | $-49,906 | $1,941 |
| EPS Basic Total Ops | 0.19 | -4.61 | -6.01 | -9.35 | 0.40 |
| EPS Basic Continuous Ops | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 |
| EPS Diluted Total Ops | 0.19 | -4.61 | -6.01 | -9.35 | 0.40 |
| EPS Diluted Continuous Ops | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 |
| EPS Diluted Before Non-Recurring Items | 0.19 | -4.61 | -6.01 | -4.72 | 0.40 |
| EBITDA(a) | $-21,826 | $-23,089 | $-25,223 | $-45,264 | $1,936 |